A multicenter, double-blind randomized placebo-controlled comparison of the effects on sexual functioning of extended-release bupropion hydrochloride (300-450mg) and escitalopram (10-20mg) in outpatients with moderate to severe major depression over an eight-week treatment period
Latest Information Update: 18 Jul 2023
At a glance
- Drugs Bupropion (Primary) ; Escitalopram
- Indications Depression; Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
- Sponsors GSK
- 01 Oct 2005 New trial record.